Medical Director Level 1
- Recruiter
- Elevate Direct
- Location
-
Brentford
South East EnglandUnited Kingdom
- Salary
- 800.00 - 990.00 GBP Daily
- Posted
- 14 Jun 2021
- Closes
- 12 Jul 2021
- Job Title
- Associate Director
- Category
- Scientific and Pharmaceutical
- Contract Type
- Permanent
- Hours
- Full Time
Title: Health Outcomes Director Europe, ViiV Healthcare - 12 Month FTC.
ViiV Healthcare is an independent, global specialist HIV company that is committed to delivering innovative new options for the care and treatment of people living with HIV/AIDS. ViiV is 100% dedicated to HIV medicines and research, and completely passionate about people affected by HIV/AIDS. As part of Research, Development and Global Medical (RDGM), the Global Health Outcomes (GHO) team is key in furthering the RDGM vision: Dedicated to delivering innovative HIV medicines, leaving no patients behind.
Our Dedication
At ViiV Healthcare we are all passionate about the difference we make and challenge ourselves every day to improve the lives of patients and consumers. That's why we have built an environment where everyone feels valued, is able to develop, contribute to our mission, and be proud of what we achieve.
The ViiV Healthcare vision is to be recognized as the most hardworking and ethical Medical organization in the HIV field, being responsible for the development of innovative and accessible treatment advances through a responsive, collaborative, and productive business model; as a result, establishing ViiV as the most trusted industry partner in HIV care around the globe, leaving no patient behind.
To support you in achieving your role and career ambitions you'll be given the opportunity to:
- Play a meaningful role in delivering our mission
- Be a crucial part of a diverse, distributed team
- Develop others as part of your own professional growth
ViiV GHO is seeking a European Health Outcomes Director to lead on activities supporting the current and growing HIV portfolio - an opportunity to apply your specialized HEOR expertise in HIV outcomes research, reimbursement and market access. GHO drives the demonstration of value for ViiV medicines, optimising patient benefit and access, with a growing focus on Real World Evidence (RWE) and Patient Centred Outcomes (PCOs). This is a FTC position with a view to end May 2022.
The current and developing ViiV portfolio requires significant HEOR input both for market access/reimbursement for current and future launches, as well as evidence generation for life cycle management. The current role will provide HEOR leadership within the European region across the ViiV portfolio, with a focus on launching assets (eg, Vocabria + Rekambys for the treatment of adults who are virologically suppressed, and Rukobia for the treatment of adults with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen), as well as supporting the planning for pipeline assets.
The ViiV portfolio also includes Dovato (dolutegravir/lamivudine), the first ever two-drug regimen indicated for treatment experienced and naïve patients. Since launching there has been a focus on demonstrating the benefits this novel new regimen in clinical practice, an effort for which Health Outcomes shares a leading responsibility.
Job Purpose
- Accountable for developing the European Health Outcomes strategy across the ViiV portfolio, with a focus on leading, managing, and implementing key evidence generation strategies to support Dovato and Vocabria + Rekambys.
- To develop a deep understanding of HEOR needs in the region, including HTA requirements and RWE, to enable and maintain successful access and uptake of ViiV's medicines across the portfolio.
- To build and maintain a positive relationship with central and local ViiV Europe stakeholders, through regular communication and collaboration with senior Regional colleagues, ensuring their awareness of Global/Regional plans and results and how they might be used in the markets.
- Responsible for life cycle access and value management including new assets, new indications, commercial deals, generic competition.
- To provide a voice for and ensure effective representation of the European region within the Global organization.
- The European lead will provide a link between the Regional and Global teams to ensure European evidence requirements for pipeline assets are reflected in the respective plans, and to facilitate the transition of assets through the peri-launch process
Responsibilities
To LEAD:
- Cross-functional Matrix working with Region and LOC medical affairs and market access to ensure integration of health outcomes studies/data to support commercialization and life cycle management.
- Integration of strategy and health outcomes studies to support ongoing access and pricing negotiations for the DTG portfolio.
- Representing/leading HO function in EU cross functional team such as EUMAT, VelVET and EU above country teams
- Drive implementation of standard methodologies and pilot innovation through the European network.
- To provide mentorship to LOCs on successful conduct of local health outcomes activities, including vendor selection, proposal evaluation, sharing of global resources, guidance and standards.
- Capability gap assessment and training requirements in health outcomes/economics in the region.
- Transparency of Regional/local and Global evidence generation activities to the IET and European network, respectively.
To PARTNER:
- Strong collaborative working within the European network and with GHO and other Global colleagues.
- Key point of contact with the LOCs for evidence generation activities.
- Interaction with vendors to develop effective study designs to ensure ongoing support for the markets.
To DELIVER:
- Responsible for life cycle access and value management including new assets, new indications, commercial deals, generic competition,
- Coordinate and drive European HEOR activities as defined in the IEP (RWE projects, economic modelling, indirect comparisons, PRO studies, etc) ensuring the scientific robustness of the study protocol, study execution, analyses, and reporting. This will either be through direct collaboration with vendors, or through the relevant GHO functions.
- Ensure payer insights are gathered globally and that they are effectively prioritised in evidence generation.
- Support country-specific adaptations of global deliverables and country reimbursement strategies across ViiV portfolio, providing input to training sessions with local country teams (eg, roll-out of Global Value Evidence Dossiers (GVDs).
- Impactful publications and downstream activities, including supporting the European medical and commercial teams with communication materials and training to ensure optimal dissemination of the evidence.
- Compliance with regulations for quality and disclosure.
- Accountable for securing, supervising and managing budgets within the scope of the role.
Basic Qualifications and Experience
- Masters degree or higher in health outcomes, health economics, epidemiology, pharmacy, health or life sciences.
- Significant experience in health outcomes or an aligned subject area/function.
- Pharmaceutical experience that includes drug development and/or and launch experience in support of value evidence generation.
- Leadership, networking, communication and influencing skills to work effectively in a sophisticated and multi-cultural Matrix environment. This role requires credibility and personal authority, to work with senior partners to develop and implement evidence generation strategies that will meet decision makers' needs.
- Self-motivated ownership and accountability for projects, to move them forward, and deliver with minimal direction.
- Understanding of the environmental/payer/access trends, needs & decision-making process in all major countries in Europe.
- Strong technical knowledge in key HEOR areas including observational research, RWE.
- Strong critical thinking strategically and tactically.
Preferred Qualifications and Experience
- Doctorate level (eg PhD, Pharm D) or higher-level degree with commensurate industry and business qualification.
- Experience in HIV/Infectious Diseases desirable but not required.
- Global R&D and/or LOC experience.